Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

GSK to acquire Affinivax for $10.6 billion

PUBLIC · GSKSep 09, 2026about 2 hours ago

Acquiring Company

GSK

Acquired Company

Affinivax

LondonUnited StatesManufacturingBiotechnologyHealth CareBiotechnologyHealth Care

Description

GSK is set to acquire US biotechnology company Affinivax for $10.6 billion. The acquisition is part of GSK's strategy to expand its operations in therapeutics and biotechnology. To fund this acquisition, GSK plans to issue approximately $6 billion in bonds. This move aims to restructure financial obligations and enhance cash flow management.

Company Information

Company

GSK

Location

London, England, United Kingdom

About

GSK is a global healthcare company engaged in the research, development, and manufacture of pharmaceutical products and vaccines. It focuses on providing innovative healthcare solutions and improving patient outcomes. The company has a strong commitment to R&D and is actively expanding its portfolio. GSK operates across more than 100 countries worldwide.

Don't miss GSK's next move

Get an email the moment GSK makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for GSK's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Affinivax?

Affinivax was acquired by GSK, based in London. The deal was reported on September 9, 2026. GSK is a global healthcare company engaged in the research, development, and manufacture of pharmaceutical products and vaccines. It focuses on providing innovative healthcare solutions and improving patient outcomes. GSK is publicly traded (GSK) and operates in Manufacturing.

When did GSK acquire Affinivax?

GSK's acquisition of Affinivax was reported on September 9, 2026. GSK is set to acquire US biotechnology company Affinivax for $10.6 billion. The acquisition is part of GSK's strategy to expand its operations in therapeutics and biotechnology. To fund this acquisition, GSK plans to issue approximately $6 billion in bonds. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Affinivax do?

Affinivax is a biotechnology company focused on developing innovative vaccines. The company leverages advanced scientific techniques to address significant public health challenges. Affinivax's mission is to improve vaccine efficacy through novel approaches. It is privately held, operating in Biotechnology, and is based in United States.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.